
A Randomized, Double-Blind, Phase IIa Dose-Finding Study of Vandetanib (ZD6474) in Japanese Patients With Non-Small Cell Lung Cancer
Keywords: سرطان غیر سلول کوچک ریه; Non-small cell lung cancer; Vandetanib; EGFR; VEGFR